Lilly pays $6.3B upfront for sleep disorder-focused Centessa in latest neuroscience play
Fuente:
FierceBiotech
Eli Lilly has gone big in the name of neuroscience, paying $6.3 billion in a front-loaded deal for Centessa Pharmaceuticals and its sleep disorder pipeline.